A Wearable mHealth Device to Promote Teenagers' Physical Activity
NCT ID: NCT02031185
Last Updated: 2016-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2014-03-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Primary Goal is to conduct a pilot randomized controlled trial (RCT) of the FitBit Flex, a popular wearable physical activity sensing device that allows data visualization and goal setting on smart phones. The target population will be adolescents ages 14-18 years old in the Seattle-metro area (n=40) with approximately 50% from low income households or belonging to a racial/ethnic minority. We will target this older age group since they have the lowest levels of physical activity among the pediatric population. This pilot study will provide feasibility and preliminary data for a future R01-funded RCT of the Flex mHealth device and app.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Data From Wearable Technology to Co-develop School-specific Physical Activity Interventions
NCT04905615
mHealth Intervention to Promote Cancer Survivors' Physical Activity
NCT02469727
A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study
NCT05217108
Adolescents' Health Through Mobile Apps, Wearables, and a Gamified TAC ( ActivA-App )
NCT06140225
Randomized Controlled Trial of a Physical Activity Program for Teenagers
NCT03081013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wait-list control
No intervention
No interventions assigned to this group
FitBit only
Participants will use the FitBit device
FitBit only
Participants will use the FitBit device
FitBit and Text Messages
Participants will use the FitBit device and receive daily affective text messages
FitBit and Text Messages
Participants will use the FitBit device and receive daily affective text messages
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FitBit only
Participants will use the FitBit device
FitBit and Text Messages
Participants will use the FitBit device and receive daily affective text messages
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* lives in the Seattle-metro area
* able to complete forms in English
* no restrictions by a health care provider on physical activity or walking
* own a smart phone or similar FitBit compatible mobile device (e.g. iPod Touch)
* agree to install and share data from the FitBit Flex smart phone app with the investigators
* attends study high school or health clinic or receives and clicks on a Facebook advertisement for the study
Exclusion Criteria
* does not live in the Seattle-metro area
* does not attend a study school or clinic, or did not receive a Facebook advertisement for the study
14 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seattle Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jason Mendoza
Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jason A Mendoza, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Megan Moreno, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seattle Children's Research Institute
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCRI-24100018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.